Related Experiment Videos

Can we measure and predict atherosclerotic progression?

¹Bowman Gray School of Medicine, Wake Forest University Medical Center, Winston-Salem, NC 27157-1063.

|March 1, 1993

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Lipoprotein-associated phospholipase A2 (Lp-PLA2) and future risk of type 2 diabetes: results from the Cardiovascular Health Study.

The Journal of clinical endocrinology and metabolism·2012

Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel.

Journal of internal medicine·2006

Effects of pravastatin on mortality in patients with and without coronary heart disease across a broad range of cholesterol levels. The Prospective Pravastatin Pooling project.

European heart journal·2002

Clinical Implications of Recent Findings from the Antihypertensive and Lipid-Lowering Treatment To Prevent Heart Attack Trial (ALLHAT) and Other Studies of Hypertension.

Annals of internal medicine·2001

Hypertension, heart rate, use of antihypertensives, and incident prostate cancer.

Annals of epidemiology·2001

Treatment of isolated systolic hypertension is most effective in older patients with high-risk profile.

Circulation·2001

See all related articles